Cargando…
Vitamin D Supplementation and COVID-19 Outcomes: Mounting Evidence and Fewer Doubts
The coronavirus disease 2019 (COVID-19) has already killed more than 6 million people around the world. A growing body of epidemiological evidence suggests that low 25-hydroxy vitamin D (25-OH-vitamin D) plasma levels are associated with an increased risk of developing COVID-19 and —most importantly...
Autores principales: | Cicero, Arrigo F. G., Fogacci, Federica, Borghi, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460517/ https://www.ncbi.nlm.nih.gov/pubmed/36079842 http://dx.doi.org/10.3390/nu14173584 |
Ejemplares similares
-
Diets, Foods and Food Components’ Effect on Dyslipidemia
por: Fogacci, Federica, et al.
Publicado: (2021) -
An Evolving Definition of a “Healthy Diet”
por: Cicero, Arrigo F. G., et al.
Publicado: (2023) -
Misinterpreting data in lipidology in the era of COVID-19
por: Fogacci, Federica, et al.
Publicado: (2020) -
Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update
por: Cicero, Arrigo F. G., et al.
Publicado: (2021) -
Nutraceuticals and Hypertensive Disorders in Pregnancy: The Available Clinical Evidence
por: Fogacci, Silvia, et al.
Publicado: (2020)